Consolidation reduced dose whole brain radiotherapy (rdWBRT) following methotrexate, rituximab, procarbazine, vincristine, cytarabine (R-MPV-A) for newly diagnosed primary CNS lymphoma (PCNSL): Final results and long-term outcome Meeting Abstract
| Authors: | Curry, R. C.; Correa, D.; Raizer, J. J.; Grimm, S. A.; Lai, R.; Schiff, D.; Grant, B. W.; Reiner, A. S.; Panageas, K.; Yahalom, J.; DeAngelis, L. M.; Abrey, L. E.; Morris, P. G.; Omuro, A. M. P. |
| Abstract Title: | Consolidation reduced dose whole brain radiotherapy (rdWBRT) following methotrexate, rituximab, procarbazine, vincristine, cytarabine (R-MPV-A) for newly diagnosed primary CNS lymphoma (PCNSL): Final results and long-term outcome |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009801560 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.2006 |
| Notes: | Meeting Abstract: 2006 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
